• How investigational compound slows kidney disease progression

    How investigational compound slows kidney disease progression

    A new strategy may help halt the progression of kidney disease in patients with diabetes. The approach, which is highlighted in an upcoming issue of the Journal of the American Society of Nephrology (JASN), addresses a common and serious complication of diabetes.

    Diabetes is the leading cause of chronic kidney disease and kidney failure, and approximately one-third of diabetic patients develop kidney disease, or diabetic nephropathy.

     

    Current diabetes therapies are often insufficient for preventing the progression of diabetic nephropathy to kidney failure, […]